Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results.

Gantenbein, Andreas R; Agosti, Reto; Kamm, Christian P; Landmann, Gunther; Meier, Niklaus; Merki-Feld, Gabriele Susanne; Petersen, Jens A; Pohl, Heiko; Ryvlin, Philippe; Schankin, Christoph J; Viceic, Dragana; Zecca, Chiara; Schäfer, Elisabeth; Meyer, Ina; Arzt, Michael E (2022). Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results. The journal of headache and pain, 23(1), p. 161. BioMed Central 10.1186/s10194-022-01530-9

[img]
Preview
Text
s10194-022-01530-9.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (729kB) | Preview

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology

UniBE Contributor:

Kamm, Christian Philipp, Schankin, Christoph Josef

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1129-2377

Publisher:

BioMed Central

Language:

English

Submitter:

Pubmed Import

Date Deposited:

20 Dec 2022 14:39

Last Modified:

25 Dec 2022 02:12

Publisher DOI:

10.1186/s10194-022-01530-9

Related URLs:

PubMed ID:

36536271

BORIS DOI:

10.48350/176157

URI:

https://boris.unibe.ch/id/eprint/176157

Actions (login required)

Edit item Edit item
Provide Feedback